Myoelectric activity of small intestine after chemical ablation of myenteric neurons.
Ablation of the myenteric plexus was performed by serosal application of 0.062% benzalkonium chloride (BAC) in the duodenum, proximal and distal jejunum, and ileum. The thickness of muscle layers and the number and sizes of ganglia and neurons of the myenteric plexus were evaluated before and 21-28 days after treatment. Electrodes were implanted on the treated segments and on segments orad and aborad to the treated segment. The electromyogram of each segment was recorded daily for periods of 2-3 h. The number of myenteric neurons in the BAC-treated segment was decreased significantly by 85 to 98% relative to segments removed before BAC application. Significantly, thickening of longitudinal plus circular muscle layers amounted to 113% in the duodenum and 261% in the ileum in the treated segment. No changes were observed in electrical slow-wave frequency in treated segments. Spike activity (percentage of slow waves with spikes) increased in the BAC-treated segment by 92% compared with recording sites orad and aborad to the treated segment and to the small intestine in untreated control animals. We interpreted the increase in spike activity in treated segments to reflect the loss of inhibitory neuronal influence. The hyperplasia and hypertrophy of the longitudinal and circular muscle coat could have resulted from a direct influence of the altered innervation or from work-induced hypertrophy in the treated segment secondary to uncoordinated hyperactivity of the disinhibited musculature.
Holle
G E
GE
Gastroenterological Research Laboratory, Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians University, Munich, Federal Republic of Germany.
Forth
W
W
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001548:Benzalkonium Compounds / Q000633:toxicity; D004594:Electrophysiology / Q000379:methods; D005725:Ganglia, Autonomic / Q000187:drug effects / Q000502:physiology; D006965:Hyperplasia; D006984:Hypertrophy; D007421:Intestine, Small / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects / Q000473:pathology / Q000502:physiology*; D009197:Myenteric Plexus / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains
D001548:Benzalkonium Compounds